Q301--Long -Term Specialized Reference Laboratory for Measurable Residual Disease (MRD) detection in hematologic malignancies - Base Plus 4 9/1/26-8/31/31
36C26026Q0807 · VETERANS AFFAIRS, DEPARTMENT OF
A MEDICAL LABORATORIES solicitation, performed in Portland, with responses due 2026-07-10. AwardCast estimates what this specific solicitation will close for, before you bid.
36C26026Q0807
solicitation
621511
NAICS
Q301
PSC
Not set aside
set-aside
Portland
place
2026-07-10
responses due
What's being bought
The VA Portland Healthcare System (VHAPORHCS) Pathology & Laboratory Medicine Service Department requires continued access to specialized testing for Measurable Residual Disease (MRD) detection in hematologic malignancies. MRD is a powerful diagnostic and prognostic tool that quantifies the presence
Comparable recent awards in MEDICAL LABORATORIES
| Winner | Award value | Offers | Date |
|---|---|---|---|
| MISCELLANEOUS FOREIGN AWARDEES | $21K | 1 | 2024-09-30 |
| MISCELLANEOUS FOREIGN AWARDEES | $84K | 1 | 2024-09-30 |
| FULGENT THERAPEUTICS LLC | $99.0M | 10 | 2024-09-30 |
| MISCELLANEOUS FOREIGN AWARDEES | $10K | 3 | 2024-09-30 |
| FULGENT THERAPEUTICS LLC | $2.3M | 1 | 2024-09-30 |
Explore the market
Comparable awards ran from $10K to $99.0M. Get AwardCast's forecast for THIS solicitation's closing price.
AwardCast forecasts what U.S. federal contracts close for, before you bid. Built on USASpending and SAM.gov. Not affiliated with the U.S. government. Technology by Chosing DEPT.